Experts hesitate on weight loss ETFs amid the obesity drug b

While weight loss drugmakers are catching a bid with investors, experts are less certain that ETFs linked to the category can achieve the same success.

Related Keywords

San Diego , California , United States , Todd Sohn , Eli Lilly , Proshare Simeon Hyman , Stratega Sohn , Health Care Select Sector , Novo Nordisk , Roundhill Investments , News ,